NOV (NYSE:NOV) Insider Joseph Rovig Sells 151,086 Shares

NOV Inc. (NYSE:NOV) insider Joseph Rovig sold 151,086 shares of the company’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $20.17, for a total transaction of $3,047,404.62. Following the completion of the sale, the insider directly owned 269,694 shares in the company, valued at $5,439,727.98. This trade represents a 35.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

NOV Price Performance

Shares of NOV opened at $20.65 on Wednesday. The business’s 50-day moving average is $17.84 and its two-hundred day moving average is $15.33. The company has a market capitalization of $7.44 billion, a P/E ratio of 54.35 and a beta of 0.93. NOV Inc. has a fifty-two week low of $10.84 and a fifty-two week high of $20.86. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.67 and a current ratio of 2.42.

NOV (NYSE:NOV) last issued its quarterly earnings data on Thursday, February 5th. The oil and gas exploration company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.23). The company had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.17 billion. NOV had a net margin of 1.66% and a return on equity of 3.57%. The business’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same period last year, the firm earned $0.41 EPS. Research analysts predict that NOV Inc. will post 1.4 earnings per share for the current year.

NOV Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 27th. Stockholders of record on Friday, March 13th will be paid a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, March 13th. This is a positive change from NOV’s previous quarterly dividend of $0.08. NOV’s dividend payout ratio is 78.95%.

Institutional Investors Weigh In On NOV

A number of hedge funds have recently modified their holdings of NOV. Price T Rowe Associates Inc. MD boosted its position in NOV by 1,743.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,059,400 shares of the oil and gas exploration company’s stock worth $79,080,000 after acquiring an additional 4,785,015 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of NOV by 585.8% during the 2nd quarter. American Century Companies Inc. now owns 5,291,529 shares of the oil and gas exploration company’s stock worth $65,774,000 after purchasing an additional 4,519,957 shares during the last quarter. First Pacific Advisors LP grew its position in shares of NOV by 101.0% in the second quarter. First Pacific Advisors LP now owns 7,018,950 shares of the oil and gas exploration company’s stock valued at $87,246,000 after purchasing an additional 3,526,754 shares in the last quarter. Ameriprise Financial Inc. increased its holdings in shares of NOV by 401.9% in the second quarter. Ameriprise Financial Inc. now owns 3,165,518 shares of the oil and gas exploration company’s stock valued at $39,347,000 after purchasing an additional 2,534,815 shares during the last quarter. Finally, First Trust Advisors LP increased its holdings in shares of NOV by 27.2% in the second quarter. First Trust Advisors LP now owns 6,091,095 shares of the oil and gas exploration company’s stock valued at $75,712,000 after purchasing an additional 1,302,214 shares during the last quarter. 93.27% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

NOV has been the topic of several analyst reports. Royal Bank Of Canada restated an “outperform” rating and set a $21.00 price target on shares of NOV in a research report on Thursday, January 15th. Susquehanna restated a “positive” rating and set a $21.00 target price on shares of NOV in a research report on Friday, February 6th. Weiss Ratings restated a “hold (c)” rating on shares of NOV in a research note on Monday, December 29th. Argus upgraded NOV to a “hold” rating in a research report on Tuesday, February 10th. Finally, Raymond James Financial restated an “outperform” rating and issued a $17.00 price objective on shares of NOV in a research report on Tuesday, October 28th. Six investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $18.36.

Trending Headlines about NOV

Here are the key news stories impacting NOV this week:

• Positive Sentiment: Analyst coverage and price targets support the stock near current levels — several firms have issued Buy/Outperform ratings and the median 6‑month price target is about $20, providing a valuation anchor for investors. QuiverQuant Note on Insider Activity & Analyst Targets
• Positive Sentiment: Selective institutional buying was reported (notably Price T. Rowe adding a large position in Q4 2025), which can underpin demand even as other funds trim exposure. QuiverQuant Institutional Activity
• Neutral Sentiment: Unrelated sector news (e.g., Novo Nordisk drug trial coverage) is circulating but does not affect NOV’s oilfield-services fundamentals. Blockonomi: Novo Nordisk Drug News
• Negative Sentiment: Large insider sale by President Joseph W. Rovig — sold 151,086 shares at ~$20.17 on Feb 23 (roughly $3.05M), reducing his holding by ~35.9%. Insider selling at this scale is typically viewed negatively by the market. SEC Filing: Rovig Sale
• Negative Sentiment: Senior VP & General Counsel Craig L. Weinstock sold shares in two transactions (70,000 shares at ~$20.08 and an earlier 10,495-share sale), trimming his position materially — another negative insider signal. SEC Filing: Weinstock Sale QuiverQuant: Weinstock Activity
• Negative Sentiment: Analyst commentary highlights operational headwinds — Zacks and other analysts point to weak Q4 drilling activity, a cautious M&A stance, and offshore/wind uncertainty, arguing for a muted near‑term outlook. That note can pressure sentiment despite technical/valuation support. Zacks: Should You Sell or Hold NOV?

NOV Company Profile

National Oilwell Varco (NYSE: NOV) is a leading provider of equipment and technology to the oil and gas industry. The company designs, manufactures and services an extensive portfolio of products used in drilling, completion and production operations. Its offerings include drilling rigs and related components, wellbore technologies such as tubulars and completion tools, surface equipment including mud pumps and blowout preventers, and aftermarket parts and services that support ongoing field operations.

NOV’s business is organized to serve upstream energy companies around the world.